On the morning of September 25, 2018, Yan Xijun, Chairman of the Board of Directors of Tasly Holding Group, led a team to the headquarters of the State Development and Investment Corporation (referred to as the State Investment Corporation).

He also held talks with Wang Huisheng, chairman of the State Investment Corporation, Qian Meng, deputy secretary of the party group, Shen Wei, chief accountant, and Wang Weidong, chairman of Guotou Chuangyi, Zhu Yonghong, General Manager of Tasly Pharmaceutical Group Co., Ltd, Ma Qiang, Vice President of Tasly Holding Group and CEO of Strategic Investment Group, Chen Yaoxiang, Managing Director of Gansu Tianshili Zhongtian Pharmaceutical Co., Ltd., Wang Zhongbin, deputy general manager of Tasly Capital's Chinese herbal medicine investment department, attended the visit.

Chairman Wang Huisheng introduced the reform and development of SDIC. He said that Tasly has a strong brand influence in the field of medicine and has made great achievements in promoting the internationalization of Chinese medicine. SDIC attaches great importance to cooperation with Tasly, and hopes to establish a cooperative communication mechanism with Tasly to jointly promote synergy and integration of the industrial chain, and leverage each other to become bigger and stronger.